Latest filing published 28 Aug 2026 for Edwards Lifesciences Corp, €204k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Annette Bruls in Edwards Lifesciences Corp. In total, 4 filings cover trades dated from 8 May 2025 to 28 August 2026.
The open-market record consists of 1 sale worth €204k, with no purchase. Outside the open market, there are 3 share grants. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 28 August 2026, reports an open-market sale of €204k in Edwards Lifesciences Corp. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations